Arlington Partners’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,125
Closed -$3.93M 68
2025
Q1
$3.93M Sell
16,125
-126
-0.8% -$31.7K 1.54% 41
2024
Q4
$4.14M Buy
16,251
+2,018
+14% +$541K 1.61% 35
2024
Q3
$4.18M Buy
14,233
+854
+6% +$241K 1.64% 34
2024
Q2
$3.24M Sell
13,379
-1,666
-11% -$397K 1.61% 27
2024
Q1
$4.02M Hold
15,045
2.05% 5
2023
Q4
$3.72M Buy
15,045
+75
+0.5% +$15.2K 1.07% 13
2023
Q3
$2.74M Buy
14,970
+14,560
+3,551% +$2.97M 1.13% 36
2023
Q2
$96.5K Sell
410
-40
-9% -$8.42K 0.01% 252
2023
Q1
$91.3K Buy
+450
New +$93.7K 0.01% 213
2022
Q1
Sell
-28
Closed -$8K 511
2021
Q4
$8K Buy
+28
New +$7.79K ﹤0.01% 507

Other funds holding EFX

Arlington Partners's EFX Position: Q2 2025 in Review

Arlington Partners sold out of Equifax (EFX) in Q2 2025, closing a stake of 16,125 shares — an estimated $3.93M sold.

Arlington Partners first reported a position in EFX in Q4 2021 and held it in 10 quarters. The position peaked at $4.18M in Q3 2024. 861 funds tracked by Wall St. Rank hold EFX as of Q2 2025.

  • Arlington Partners reported no remaining Equifax position as of Q2 2025 after selling out during the quarter.
  • Arlington Partners sold 16,125 Equifax shares in Q2 2025, an estimated $3.93M.
  • Arlington Partners first reported a position in Equifax in Q4 2021 and held it in 10 quarters.
  • Arlington Partners's Equifax position peaked at $4.18M in Q3 2024.
  • 861 funds tracked by Wall St. Rank held Equifax as of Q2 2025.

Based on Arlington Partners's 13F filing for Q2 2025, filed 14 Jul 2025.